[1]朱海佳,周秋君,杨慧凤,等.干细胞移植联合髓芯减压治疗早中期股骨头坏死的Meta分析[J].中医正骨,2021,33(06):21-26+35.
　ZHU Haijia,ZHOU Qiujun,YANG Huifeng,et al.Stem cell transplantation combined with core decompression for treatment of early-middle osteonecrosis of the femoral head:a meta analysis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(06):21-26+35.
点击复制

干细胞移植联合髓芯减压治疗早中期股骨头坏死的Meta分析()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第33卷
期数:
2021年06期
页码:
21-26+35
栏目:
文献研究
出版日期:
2021-06-20

文章信息/Info

Title:
Stem cell transplantation combined with core decompression for treatment of early-middle osteonecrosis of the femoral head:a meta analysis
作者:
朱海佳1; 周秋君1; 杨慧凤1; 张善星2; 肖鲁伟2
1.浙江中医药大学第一临床医学院,浙江 杭州 310053; 2.浙江省中医院,浙江 杭州 310006
Author(s):
ZHU Haijia1; ZHOU Qiujun1; YANG Huifeng1; ZHANG Shanxing2; XIAO Luwei2
1.The First Clinical Medical College of Zhejiang Chinese Medical University,Hangzhou 310053,Zhejiang,China 2.Zhejiang Provincial Hospital of Traditional Chinese Medicine,Hangzhou 310006,Zhejiang,China
关键词:
股骨头坏死;  干细胞移植;  减压术; 外科;  Meta分析;  系统评价
Keywords:
femur head necrosis;  stem cell transplantation;  decompression; surgical;  meta-analysis;  systematic review
摘要:
目的:评价干细胞移植联合髓芯减压治疗早中期股骨头坏死(osteonecrosis of the femoral head,ONFH)的临床疗效。方法:应用计算机检索万方、中国知网、维普、中国生物医学文献数据库及PubMed、Springer、Embase数据库中关于干细胞移植联合髓芯减压治疗早中期ONFH的随机对照临床研究文献,检索时限为建库至2020年6月。试验组采用干细胞移植联合髓芯减压治疗ONFH,对照组采用单纯髓芯减压治疗。由2名研究者根据纳入和排除标准独立检索、筛选文献并提取资料,采用Cochrane偏倚风险评估工具对纳入文献的质量进行评估,采用RevMan5.3软件进行Meta分析。结果:共检索出587篇文献,最终纳入13篇文献。Meta分析结果表明,试验组术后Harris髋关节评分高于对照组[I2=45%,P=0.080; MD=11.80,95%CI(10.66,12.94)],西安大略和麦克马斯特大学骨关节炎指数低于对照组[I2=0%,P=0.650; MD=-17.87,95%CI(-19.34,-16.40)],术后髋关节疼痛视觉模拟量表评分低于对照组[I2=86%,P=0.000; MD=-1.32,95%CI(-1.60,-1.05)],术后股骨头严重塌陷或关节退行性变的发生率低于对照组[I2=0%,P=0.960; OR=0.18,95%CI(0.08,0.39)],术后股骨头坏死区面积占股骨头面积的百分比低于对照组[I2=0%,P=0.790; MD=-5.44,95%CI(-6.44,-4.45)]。结论:现有的证据表明,干细胞移植联合髓芯减压治疗早中期ONFH的临床疗效优于单纯髓芯减压。
Abstract:
Objective:To evaluate the clinical curative effects of stem cell transplantation(SCT)combined with core decompression(CD)for treatment of early-middle osteonecrosis of the femoral head(ONFH).Methods:All the randomized controlled trial(RCT)articles about SCT combined with CD for treatment of early-middle ONFH included from database establishing to June 2020 were retrieved from Wanfang Database,China National Knowledge Internet,VIP Database,Chinese Biomedical Literature Database,PubMed,Springer and Embase through computer.The patients in experimental group were treated with SCT and CD,while the ones in control group were merely treated with CD.The articles were retrieved and screened and the information was extracted independently by two searchers according to the inclusion and exclusion criteria.The methodological quality of research in the articles was evaluated by using Cochrane risk bias assessment tools and a Meta-analysis was conducted by using RevMan5.3 software.Results:Five hundred and eighty-seven articles were searched out.After screening,13 articles were included in the final analysis.The results of Meta-analysis revealed that the postoperative Harris hip scores were higher,while the Western Ontario and McMaster Universities(WOMAC)osteoarthritis indexes,the postoperative hip pain visual analogue scale(VAS)scores,incidence of severe collapse of femoral head or degeneration of joint and proportion of femoral head necrotic area to whole femoral head area were lower in experimental group compared to control group(I2=45%,P=0.080; MD=11.80,95%CI(10.66,12.94); I2=0%,P=0.650; MD=-17.87,95%CI(-19.34,-16.40); I2=86%,P=0.000; MD=-1.32,95%CI(-1.60,-1.05); I2=0%,P=0.960; OR=0.18,95%CI(0.08,0.39); I2=0%,P=0.790; MD=-5.44,95%CI(-6.44,-4.45)).Conclusion:Available evidences suggest that the clinical curative effect of combination therapy of SCT and CD is better than that of monotherapy of CD in treatment of early-middle ONFH.

参考文献/References:

[1] ARBAB D,K?NIG D P.Atraumatic femoral head necrosis in adults[J].Dtsch Arztebl Int,2016,113(3):31-38.
[2] LIEBERMAN J R,BERRY D J,MONTV M A,et al.Osteonecrosis of the hip:management in the twenty-first century[J].J Bone Joint Surg Am,2002,84(5):834-853.
[3] MALIZOS K N,KARANTANAS A H,VARITIMIDIS S E,et al.Osteonecrosis of the femoral head:etiology,imaging and treatment[J].Eur J Radiol,2007,63(1):16-28.
[4] MARKER D R,SEYLER T M,ULRICH S D,et al.Do modern techniques improve core decompression outcomes for hip osteonecrosis?[J].Clin Orthop Relat Res,2008,466(5):1093-1103.
[5] LIEBERMAN J R,ENGSTROM S M,MENEGHINI R M,et al.Which factors influence preservation of the osteonecrotic femoral head?[J].Clin Orthop Relat Res,2012,470(2):525-534.
[6] 孟和,王和鸣.中西医结合微创骨科学[M].北京:人民卫生出版社,2015:2385-2405.
[7] 张维新,童培建.干细胞移植治疗股骨头坏死的研究进展[J].中医正骨,2019,31(5):28-30.
[8] MA Y,WANG T,LIAO J,et al.Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head:a prospective,double-blinded,randomized,controlled study[J].Stem Cell Res Ther,2014,5(5):115.
[9] RASTOGI S,SANKINEANI S R,NAG H L,et al.Intra-lesional autologous mesenchymal stem cells in management of osteonecrosis of femur:a preliminary study[J].Musculoskelet Surg,2013,97(3):223-228.
[10] SEN R K,TRIPATHY S K,AGGARWAL S,et al.Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis:a randomized control study[J].J Arthroplasty,2012,27(5):679-686.
[11] REZA M T,SABERI S,PARVIZI J,et al.Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head:a comparative study[J].J Arthroplasty,2015,30(9 Suppl):11-15.
[12] ZHAO D,CUI D,WANG B,et al.Treatment of early stage osteonecrosis of the femoral head with autologous implan-tation of bone marrow-derived and cultured mesenchymal stem cells[J].Bone,2012,50(1):325-330.
[13] 郭小伟,吴卫新,洪云飞,等.髓芯减压并自体骨髓干细胞移植治疗股骨头缺血性坏死[J].医药论坛杂志,2008,29(5):19-21.
[14] 韩贤明.髓心减压联合自体骨髓间充质干细胞移植对股骨头坏死患者术后血流动力学的影响[J].中外医学研究,2018,16(35):51-53.
[15] 李磊,杨宇,蔡立雄,等.髓芯减压联合自体浓缩骨髓有核细胞移植治疗早期股骨头坏死[J].重庆医学,2015,44(3):343-344.
[16] 李民,李书奎,陈汉文,等.髓芯减压后自体MCS移植治疗早期股骨头坏死效果[J].齐鲁医学杂志,2016,31(3):340-341.
[17] 孙薏,张文华,姚一民,等.中心减压植骨联合骨髓间充质干细胞移植治疗股骨头缺血坏死[J].西南国防医药,2008,18(6):800-802.
[18] 肖兴雷,刘尚伦,陈宏伟,等.髓芯减压联合间充质干细胞移植治疗早期股骨头坏死的效果[J].中国医药导报,2015,12(33):113-116.
[19] 余莲,邱永荣,陈隆天,等.自体外周血干细胞移植联合髓芯减压治疗早中期股骨头缺血性坏死的临床研究[J].中华细胞与干细胞杂志(电子版),2013,3(3):12-16.
[20] 赵日光,刘宏滨,韩冰,等.髓芯减压联合自体骨髓干细胞移植治疗早期股骨头缺血性坏死的疗效观察[J].人民军医,2016,59(4):372-373.
[21] FAIRBANK A C,BHATIA D,JINNAH R H,et al.Long-term results of core decompression for ischaemic necrosis of the femoral head[J].J Bone Joint Surg Br,1995,77(1):42-49.
[22] MONT M A,CARBONE J J,FAIRBANK A C.Core decompression versus nonoperative management for osteonecrosis of the hip[J].Clin Orthop Relat Res,1996(324):169-178.
[23] DALTRO G C,FORTUNA V,DE SOUZA E S,et al.Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease:a five-year follow-up study[J].Stem Cell Res Ther,2015,6(1):110.
[24] SUH K T,KIM S W,ROH H L,et al.Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis[J].Clin Orthop Relat Res,2005(431):220-225.
[25] LEE J S,LEE J S,ROH H L,et al.Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head:comparative analysis according to the risk factor[J].J Orthop Res,2006,24(4):604-609.
[26] HERNIGOU P,POIGNARD A,ZILBER S,et al.Cell therapy of hip osteonecrosis with autologous bone marrow graft-ing[J].Indian J Orthop,2009,43(1):40-45.

相似文献/References:

[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型 血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
　XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2 在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
　ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
　ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成 最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
　LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗 ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
　ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(06):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
　ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(06):20.
[11]张维新,童培建.干细胞移植治疗股骨头坏死的研究进展[J].中医正骨,2019,31(05):28.

备注/Memo

备注/Memo:
基金项目:浙江省大学生科技创新活动计划暨新苗人才计划项目(2019R410050)
通讯作者:肖鲁伟 E-mail:xlw@139.com
更新日期/Last Update: 2021-12-20